Kola I - Search Results

1

ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.

Wolvetang EJ, Wilson TJ, Sanij E, Busciglio J, Hatzistavrou T, Seth A, Hertzog PJ, Kola I. Wolvetang EJ, et al. Among authors: kola i. Hum Mol Genet. 2003 Feb 1;12(3):247-55. doi: 10.1093/hmg/ddg015. Hum Mol Genet. 2003. PMID: 12554679

2

Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Xu D, Wilson TJ, Chan D, De Luca E, Zhou J, Hertzog PJ, Kola I. Xu D, et al. Among authors: kola i. EMBO J. 2002 Aug 1;21(15):4081-93. doi: 10.1093/emboj/cdf413. EMBO J. 2002. PMID: 12145208 Free PMC article.

3

Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.

Sumarsono SH, Wilson TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A, Kola I. Sumarsono SH, et al. Among authors: kola i, kola r. Nature. 1996 Feb 8;379(6565):534-7. doi: 10.1038/379534a0. Nature. 1996. PMID: 8596630

4

Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome.

Kola I, Hertzog PJ. Kola I, et al. Hum Mol Genet. 1997;6(10):1713-27. doi: 10.1093/hmg/6.10.1713. Hum Mol Genet. 1997. PMID: 9300664 Review.

5

Down syndrome and mouse models.

Kola I, Hertzog PJ. Kola I, et al. Curr Opin Genet Dev. 1998 Jun;8(3):316-21. doi: 10.1016/s0959-437x(98)80088-9. Curr Opin Genet Dev. 1998. PMID: 9690992 Review.

6

Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome.

Sanij E, Hatzistavrou T, Hertzog P, Kola I, Wolvetang EJ. Sanij E, et al. Among authors: kola i. Biochem Biophys Res Commun. 2001 Oct 5;287(4):1003-8. doi: 10.1006/bbrc.2001.5680. Biochem Biophys Res Commun. 2001. PMID: 11573964

7

Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.

Chan D, Wilson TJ, Xu D, Cowdery HE, Sanij E, Hertzog PJ, Kola I. Chan D, et al. Among authors: kola i. Br J Cancer. 2003 Jan 13;88(1):137-45. doi: 10.1038/sj.bjc.6600669. Br J Cancer. 2003. PMID: 12556973 Free PMC article.

8

The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.

Wolvetang EW, Bradfield OM, Tymms M, Zavarsek S, Hatzistavrou T, Kola I, Hertzog PJ. Wolvetang EW, et al. Among authors: kola i. Biochim Biophys Acta. 2003 Jul 28;1628(2):105-10. doi: 10.1016/s0167-4781(03)00121-0. Biochim Biophys Acta. 2003. PMID: 12890557

9

Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.

Wolvetang EJ, Bradfield OM, Hatzistavrou T, Crack PJ, Busciglio J, Kola I, Hertzog PJ. Wolvetang EJ, et al. Among authors: kola i. Neurobiol Dis. 2003 Dec;14(3):349-56. doi: 10.1016/s0969-9961(03)00107-4. Neurobiol Dis. 2003. PMID: 14678752

10

Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium.

Ng AY, Waring P, Ristevski S, Wang C, Wilson T, Pritchard M, Hertzog P, Kola I. Ng AY, et al. Among authors: kola i. Gastroenterology. 2002 May;122(5):1455-66. doi: 10.1053/gast.2002.32990. Gastroenterology. 2002. PMID: 11984530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters